# Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies

Review · Bruno Pietro Imbimbo, Stefania Ippati, Mark Watling, Camillo Imbimbo

- Archive id: doi:10.1016/j.phrs.2022.106631
- Published: 2022-12-28
- Venue: Pharmacological Research
- DOI: https://doi.org/10.1016/j.phrs.2022.106631
- PMID: 36586644
- Citations: 66
- Source URL: https://doi.org/10.1016/j.phrs.2022.106631
- PDF: https://www.sciencedirect.com/science/article/pii/S1043661822005771/pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.